Spectral Medical Inc EDTXF

Unexplained

[palinc2000]

Assuming Spectral mgmt take their  fiduciary responsibility seriously it is inconceivable that they accepted a minucule milestone payment of only 2 million dollrs cad from Baxter who has a market Cap of over 21 Billion US Dollrs ...if in fact the odds of successful results  after the 90 patient milestone is reported by some to be over 95 %,,,,,Especially in light of apparently over 30% dilution will be needed to get us to FDA approval......SOMETHING DOES NOT ADD UP

Why was the 2 million milestone payment not mentioned in the PR and not mentioned in the CC until asked at the end of the CC

Why have they not disclosed the milestone payment upon FDA approval?
There are no competitive downfall in revealing this amount .....

Some say that Baxter is calling the shot  ....that makes no sense

I have not encounterd bashers in this MB as questioning mgmts actions in search of the truth is what is needed,,,The endless pumping  by some contributes NOTHING....

[hmmmmmmmm]

The 2M was Baxter's option to exercise as set out in the original Feb 4, 2020 contract. It was originally (redacted) but believed to be 5M but Spectral borrowed 2.5M early. That said, the way Spectral has decided not to disclose information around this "Milestone" are not just fair questions, they should be an obvious questions to any shareholder. Like: Why did "exceeding